Gumikas, Aminah S.
HRN: 14-85-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/18/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
01/18/2024
01/25/2024
IV
1.5grams
Every 8hours
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes